ABACAVIR AND LAMIVUDINE

Generic: ABACAVIR AND LAMIVUDINE

Laurus Labs LimitedManufacturer
ORALRoute
ABACAVIR SULFATEActive Substance
2022-07-25Original Approval

ABACAVIR AND LAMIVUDINE is FDA application ANDA216332, sponsored by LAURUS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
PYREXIA
634 reports
2
OFF LABEL USE
594 reports
3
EXPOSURE DURING PREGNANCY
579 reports
4
HEPATIC ENZYME INCREASED
567 reports
5
PAIN
530 reports
6
NAUSEA
526 reports
7
TREATMENT FAILURE
516 reports
8
RASH
504 reports
9
HYPERTENSION
496 reports
10
HEADACHE
491 reports